Author

Amrita Barua

The University of Texas MD Anderson Cancer CenterORCID 0009-0008-8879-3776Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Bhagya Shree ChoudharyiD· 1 shared David H. PengiD· 1 shared Don Lynn GibbonsiD· 1 shared Jared J. FradetteiD· 1 shared Jing WangiD· 1 shared Lixia DiaoiD· 1 shared Samrat T. KunduiD· 1 shared Sofia Garza· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Bhagya Shree ChoudharyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintDec 25, 2025

PDK1 and YAP1/TEAD signaling drive acquired KRAS inhibitor resistance in KRAS-mutant non-small cell lung cancer.

Amrita Barua, Samrat T. Kundu, Sofia Garza…·Don Lynn Gibbons

This study identifies PDK1 and YAP1/TEAD signaling as drivers of acquired resistance to KRAS inhibitors in NSCLC and suggests their co-targeting as a potential therapeutic strategy.

DOI 10.64898/2025.12.22.696060

humanbulk RNA-seq

𝕏 PostBluesky